Higher preoperative serum levels of PD ‐L1 and B7‐H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF ‐targeted therapy and unfavorable prognosis of renal cell carcinoma-Reference-Cited by-同舟云学术

Higher preoperative serum levels of PD ‐L1 and B7‐H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF ‐targeted therapy and unfavorable prognosis of renal cell carcinoma

Published:2016-06-12 Issue:8 Volume:5 Page:1810-1820
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Fukuda Takehiko¹,Kamai Takao¹,Masuda Akinori²,Nukui Akinori³,Abe Hideyuki¹,Arai Kyoko¹,Yoshida Ken‐Ichiro¹

Affiliation:

1. Department of Urology Dokkyo Medical University Tochigi Japan

2. Dialysis center Dokkyo Medical University Koshigaya Hospital Saitama Japan

3. Department of Urology Nasu Red Cross Hospital Tochigi Japan

Funder

Japanese Science Progress Society KAKENHI

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.754

Reference35 articles.

1. Cancer statistics, 2012

2. Renal cell carcinoma

3. The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer

4. Proliferative activity of intratumoral CD8(+) T‐lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity;Nakano O.;Cancer Res.,2001

5. Human renal carcinoma antigen‐specific CTLs, antigen‐driven selection and long‐term persistence in vivo;Jantzer P.;Cancer Res.,1998

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B7H4 Role in Solid Cancers: A Review of the Literature;Cancers;2024-07-11

2. Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies;Journal of Experimental & Clinical Cancer Research;2024-05-31

3. PD-L1 as a Urine Biomarker in Renal Cell Carcinoma—A Case Series and Proof-of-Concept Study;Diagnostics;2024-03-30

4. Meta-analysis of the prognostic value of soluble programmed death ligand-1 (sPD-L1) in cancers;Biomarkers;2023-07-02

5. Association between response to anti-PD-1 treatment and blood soluble PD-L1 and IL-8 changes in patients with NSCLC;Discover Oncology;2023-03-29